ACE inhibitor cough — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Switch to an angiotensin-II receptor blocker after prescriber review
This scenario assesses ACE inhibitor cough in a UK pharmacy practice context. A persistent dry cough is a recognised ACE inhibitor adverse effect, and an ARB is a usual alternative when clinically suitable. The best answer is Switch to an angiotensin-II receptor blocker after prescriber review because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.
Reference: BNF; NICE CKS